What Is a “Good” Treatment Decision? Decisional Control,Knowledge,Treatment Decision Making,and Quality of Life in Men with Clinically Localized Prostate Cancer
Restricted accessResearch articleFirst published online August, 2016
What Is a “Good” Treatment Decision? Decisional Control,Knowledge,Treatment Decision Making,and Quality of Life in Men with Clinically Localized Prostate Cancer
Objective. We explored whether active patient involvement in decision making and greater patient knowledge are associated with better treatment decision-making experiences and better quality of life (QOL) among men with clinically localized prostate cancer. Localized prostate cancer treatment decision making is an advantageous model for studying patient treatment decision-making dynamics because there are multiple treatment options and a lack of empirical evidence to recommend one over the other; consequently, it is recommended that patients be fully involved in making the decision. Methods. Men with newly diagnosed clinically localized prostate cancer (N = 1529) completed measures of decisional control, prostate cancer knowledge, and decision-making experiences (decisional conflict and decision-making satisfaction and difficulty) shortly after they made their treatment decision. Prostate cancer–specific QOL was assessed at 6 months after treatment. Results. More active involvement in decision making and greater knowledge were associated with lower decisional conflict and higher decision-making satisfaction but greater decision-making difficulty. An interaction between decisional control and knowledge revealed that greater knowledge was only associated with greater difficulty for men actively involved in making the decision (67% of sample). Greater knowledge, but not decisional control, predicted better QOL 6 months after treatment. Conclusions. Although men who are actively involved in decision making and more knowledgeable may make more informed decisions, they could benefit from decisional support (e.g., decision-making aids, emotional support from providers, strategies for reducing emotional distress) to make the process easier. Men who were more knowledgeable about prostate cancer and treatment side effects at the time that they made their treatment decision may have appraised their QOL as higher because they had realistic expectations about side effects.
WiltTJBrawerMKJonesKM. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012;367(3):203–13.
2.
SunFOyesanmiOFontanarosaJRestonJGuzzoTSchoellesK. Therapies for Clinically Localized Prostate Cancer: Update of a 2008 Systematic Review. Comparative Effectiveness Reviews No. 146. Report No. 15-EHC004-EF. Rockville (MD): Agency for Healthcare Research and Quality; 2014.
3.
FowlerFJJr.GallagherPMDrakeKMSepuchaKR. Decision dissonance: evaluating an approach to measuring the quality of surgical decision making. Jt Comm J Qual Patient Saf. 2013;39(3):136–44.
4.
Center for the Evaluative Clinical Sciences.A Dartmouth Atlas Project Topic Brief: Preference-Sensitive Care. Lebanon (NH): Dartmouth Medical School; 2007.
5.
O’ConnorAMLlewellyn-ThomasHAFloodAB. Modifying unwarranted variations in health care: shared decision making using patient decision aids. Health Aff (Millwood). 2004;Suppl Variation:VAR63–72.
6.
AningJJWassersugRJGoldenbergSL. Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret. Curr Oncol. 2012;19(Suppl 3):S37–44.
7.
BerryDLWangQHalpennyBHongF. Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer. Patient Educ Couns. 2012;88(2):262–7.
8.
ThompsonIThrasherJBAusG. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007;177:2106–31.
9.
MakoulGClaymanML. An integrative model of shared decision making in medical encounters. Patient Educ Couns. 2006;60(3):301–12.
10.
CharlesCGafniAWhelanT. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997;44(5):681–92.
PalmerNRAToozeJATurnerARXuJAvisNE. African American prostate cancer survivors’ treatment decision-making and quality of life. Patient Educ Couns. 2013;90(1):61–8.
13.
HackTFDegnerLFWatsonPSinhaL. Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancer. Psychooncology. 2006;15(1):9–19.
14.
FischerMVisserAVoermanB. Treatment decision making in prostate cancer: patients’ participation in complex decisions. Patient Educ Couns. 2006;63(3):308–13.
15.
KremerHIronsonGSchneidermanNHautzingerM. "It’s my body": does patient involvement in decision making reduce decisional conflict?Med Decis Making. 2007;27(5):522–32.
16.
CharlesCGafniAWhelanT. Decision-making in the physician–patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med. 1999;49(5):651–61.
17.
KaplanALCrespiCMSaucedoJDConnorSELitwinMSSaigalCS. Decisional conflict in economically disadvantaged men with newly diagnosed prostate cancer: baseline results from a shared decision-making trial. Cancer. 2014;120(17):2721–7.
18.
ShafirARosenthalJ. Shared decision making: advancing patient-centered care through state and federal implementation. Available from: www.nashp.org.
19.
WashingtonAELipsteinSH. The Patient-Centered Outcomes Research Institute: promoting better information, decisions, and health. N Engl J Med. 2011;365(15):e31.
20.
O’ConnorAMBennettCStaceyD. Do patient decision aids meet effectiveness criteria of the International Patient Decision Aid Standards Collaboration? A systematic review and meta-analysis. Med Decis Making. 2007;27(5):554–74.
21.
HoveyRBCuthbertsonKESBirnieKA. The influence of distress on knowledge transfer for men newly diagnosed with prostate cancer. J Cancer Educ. 2012;27(3):540–5.
22.
GwedeCPow-SangJSeigneJ. Treatment decision-making strategies and influences in patients with localized prostate carcinoma. Cancer. 2005;104(7):1381–90.
23.
OromHPennerLAWestBTDownsTMRayfordWUnderwoodWIII. Personality predicts prostate cancer treatment decision-making difficulty and satisfaction. Psychooncology. 2009;18(3):290–9.
24.
SohlSJSchnurJBMontgomeryGH. A meta-analysis of the relationship between response expectancies and cancer treatment-related side effects. J Pain Symptom Manage. 2009;38(5):775–84.
25.
LevyAGHersheyJC. Distorting the probability of treatment success to justify treatment decisions. Organ Behav Hum Decis Process. 2006;101(1):52–8.
26.
DeibertCMMaliskiSKwanLFinkAConnorSELitwinMS. Prostate cancer knowledge among low income minority men. J Urol. 2007;177(5):1851–5.
27.
DegnerLFSloanJA. Decision making during serious illness: what role do patients really want to play?J Clin Epidemiol. 1992;45(9):941–50.
28.
O’ConnorAM. Validation of a decisional conflict scale. Med Decis Making. 1995;15(1):25–30.
Holmes-RovnerMKrollJSchmittN. Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Making. 1996;16(1):56–64.
31.
WeiJTDunnRLLitwinMSSandlerHMSandaMG. Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899–905.
DenbergTDKimFJFlaniganRC. The influence of patient race and social vulnerability on urologist treatment recommendations in localized prostate carcinoma. Med Care. 2006;44(12):1137–41.
35.
HarlanLPotoskyAGillilandF. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst. 2001;93(24):1864.
36.
FallowfieldL. Psychosocial adjustment after treatment for early breast cancer. Oncology (Williston Park). 1990;4(4):89–97, discussion 97–8, 100.
37.
LeporeSJHelgesonVSEtonDTSchulzR. Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychol. 2003;22(5):443–52.
38.
KimYRoscoeJAMorrowGR. The effects of information and negative affect on severity of side effects from radiation therapy for prostate cancer. Support Care Cancer. 2002;10(5):416–21.
39.
BarryMJEdgman-LevitanS. Shared decision making: the pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780–1.
40.
Institute of Medicine. Crossing the Quality Chasm. Washington, DC: National Academy Press; 2001.
41.
EpsteinRMFiscellaKLesserCSStangeKC. Why the nation needs a policy push on patient-centered health care. Health Aff (Millwood). 2010;29(8):1489–95.
42.
WongFStewartDEDanceyJ. Men with prostate cancer: influence of psychological factors on informational needs and decision making. J Psychosom Res. 2000;49:13–9.
43.
SinghJASloanJAAthertonPJ. Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the control preferences scale. Am J Manag Care. 2010;16(9):688–96.
44.
ReynaVFNelsonWLHanPKPignoneMP. Decision making and cancer. Am Psychol. 2015;70(2):105.
45.
NorthouseLLMoodDWSchafenackerA. Randomized clinical trial of a family intervention for prostate cancer patients and their spouses. Cancer. 2007;110(12):2809–18.
46.
EchlinKNReesCE. Information needs and information-seeking behaviors of men with prostate cancer and their partners: a review of the literature. Cancer Nurs. 2002;25(1):35–41.
47.
ResendesLAMcCorkleR. Spousal responses to prostate cancer: an integrative review. Cancer Invest. 2006;24(2):192–8.
48.
FallerHSchulerMRichardMHecklUWeisJKüffnerR. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol. 2013;31(6):782–93.
49.
StaceyDLegareFColNF. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014;1:CD001431.
50.
ViolettePDAgoritsasTAlexanderP. Decision aids for localized prostate cancer treatment choice: systematic review and meta-analysis. CA Cancer J Clin. 2015;65(3):239–51.
51.
HackTFDegnerLFParkerPA. The communication goals and needs of cancer patients: a review. Psychooncology. 2005;14(10):831–45.
52.
BanduraA. Self-Efficacy: The Exercise of Control. New York: Freeman;1997.
53.
TatrowKMontgomeryG. Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: a meta-analysis. J Behav Med. 2006;29(1):17–27.
54.
WangDSJaniABTaiCG. Severe lack of comprehension of common prostate health terms among low-income inner-city men. Cancer. 2013;119(17):3204–11.
55.
LopezMKaplanCPNapolesA. Satisfaction with treatment decision-making and treatment regret among Latinas and non-Latina whites with DCIS. Patient Educ Couns. 2014;94(1):83–9.
56.
ManciniJGenreDDalencF. Patient’s regret after participating in a randomized controlled trial depended on their involvement in the decision making. J Clin Epidemiol. 2012;65:635–42.
57.
BrehautJCO’ConnorAMWoodTJ. Validation of a decision regret scale. Med Decis Making. 2003;23(4):281–92.
